Chan, Y. (Ophavsperson), Chao, T. (Ophavsperson), Chen, S. (Ophavsperson), Lee, H. (Ophavsperson), Li, P. (Ophavsperson), Chen, W. (Ophavsperson), Yeh, Y. (Ophavsperson), Kuo, C. (Ophavsperson), See, L. (Ophavsperson), Lip, G. Y. H. (Ophavsperson) (
28 jun. 2022). Additional file 4 of The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study. Figshare.
10.6084/m9.figshare.20176135.v1